Emerging Companies
April 17, 2013
|
April 15, 2013
|
February 25, 2013
|
February 12, 2013
|
Letters, Testimony & Comments
July 26 2012
Jeffrey S. Hatfield, President and Chief Executive Officer, Vitae Pharmaceuticals
On behalf of the Biotechnology Industry...
March 16 2012
Dear Majority Leader Reid and Minority Leader McConnell:
On behalf of the Biotechnology Industry Organization (BIO) and its more than 1...
March 6 2012
William D. Waddill, Senior Vice President and Chief Financial Officer OncoMed Pharmaceuticals highlights the importance of capital...
December 1 2011
On December 1, BIO submitted written testimony to the Senate Committee on Banking, Housing, and Urban Affairs on the importance of...
May 25 2011
Good morning Chairman Casey, Vice Chairman Brady, Ranking Member DeMint, Ranking Member Hinchey, Members of the Committee, ladies, and...
Press Releases
May 21 2013
The Biotechnology Industry Organization (BIO) announced today it has joined the Coalition of Small Business...
May 16 2013
Washington, D.C. (May 16, 2013) – The Biotechnology Industry Organization (BIO) today lauds the House of...
May 15 2013
The Biotechnology Industry Organization (BIO) today thanks Representative David Schweikert (R-AZ) for introducing H.R...
January 8 2013
WASHINGTON DC, January 8, 2013 -- BIO lauds the Administration and the U.S. Small Business Association (SBA) for...
September 25 2012
Washington, D.C. (September 25, 2012) – The Biotechnology Industry Organization (BIO) applauds Sens. Robert...
Want to learn more about the biotech industry?
Business Solutions Sponsor
